SEC Company Response from Voyager Therapeutics, (VYGR) — Nov 27, 2019
Voyager Therapeutics, Inc.
Date: Nov. 27, 2019 · CIK: 0001640266 · Accession: 0001104659-19-068177
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-234527
Letter
VOYAGER THERAPEUTICS, INC.
75 Sidney Street
Cambridge, MA 02139
November 27, 2019
VIA EDGAR SUBMISSION
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Voyager Therapeutics, Inc. Registration Statement on Form S-3 File No. 333-234527 Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Voyager Therapeutics, Inc. hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-234527), so that it may become effective at 4:00 p.m., Eastern time, on December 2, 2019, or as soon as practicable thereafter.
Very truly yours,
VOYAGER THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm VOYAGER THERAPEUTICS, INC. 75 Sidney Street Cambridge, MA 02139 November 27, 2019 VIA EDGAR SUBMISSION Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Voyager Therapeutics, Inc. Registration Statement on Form S-3 File No. 333-234527 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Voyager Therapeutics, Inc. hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-234527), so that it may become effective at 4:00 p.m., Eastern time, on December 2, 2019, or as soon as practicable thereafter. Very truly yours, VOYAGER THERAPEUTICS, INC. By: /s/ Robert W. Hesslein Name: Robert W. Hesslein Title: Senior Vice President & General Counsel